One of the biggest future trends in healthcare is “personalized medicine”. Personalized medicine refers to medical care based around the genetic makeup of …
Illumina, Inc. (NASDAQ:ILMN) announced that it, and its wholly owned subsidiary,Verinata Health, Inc.
Analysts weigh in on healthcare stocks Celgene Corporation (NASDAQ:CELG) and Illumina, Inc. (NASDAQ:ILMN) amid the earnings frenzy.
While Illumina, Inc. (NASDAQ:ILMN) disappointed investors by lowering revenue outlook, Heron Therapeutics Inc (NASDAQ:HRTX) started the week off strong with good news from …
Illumina, Inc. (NASDAQ:ILMN) announced estimated first quarter revenue of approximately $572 million, a 6% increase compared to $539 million in the first quarter of 2015 …
Illumina, Inc. (NASDAQ:ILMN) announced that Jay Flatley, current Chairman and CEO, will assume the role of Executive Chairman of the Board of Directors …
Illumina, Inc. (NASDAQ:ILMN) announced that the company filed lawsuits againstOxford Nanopore Technologies Ltd.
Illumina, Inc. (NASDAQ:ILMN) and Genomics England announce a partnership to develop a platform and knowledge base that can be used to improve and automate …
Illumina, Inc. (NASDAQ:ILMN) announced its financial results for the fourth quarter and fiscal year 2015.
Illumina, Inc. (NASDAQ:ILMN) announced it has signed four separate biobanking deals with Vanderbilt University, University of Colorado at Denver, Partners HealthCare, and Montreal Heart …
